Corresponding author: E.N. Barker, School of Veterinary Sciences, University of Bristol, Langford, Bristol BS40 5DU, UK; e-mail: email@example.com.
Feline coronavirus (FCoV) infection is common. In a small percentage of cats, FCoV infection is associated with the fatal disease feline infectious peritonitis (FIP). Genetically distinct virulent and avirulent strains of FCoV might coexist within a cat population.
To determine whether the strains of FCoV in FIP-affected cats are closely related or genetically distinct from the fecally derived strains of FCoV in contemporary-asymptomatic cats during an epizootic outbreak of FIP.
Four cats euthanized because of FIP and 16 asymptomatic cats.
This prospective outbreak investigation was initiated during an outbreak of FIP in cats within or rehomed from a rescue/rehoming center. Postmortem samples were collected from cats with FIP and contemporaneous fecal samples from asymptomatic cats. RNA was purified from tissue and fecal samples, FCoV gene fragments were reverse transcribed, PCR-amplified using novel primers, and sequenced. Sequences were aligned with ClustalW and compared with published FCoV sequences.
FCoV RNA was detected in all 4 FIP cat postmortem samples and in 9 of the 16 fecal samples from contemporary-asymptomatic cats. Novel primers successfully amplified fragments from 4 regions of the genome for all FCoV-positive samples. Phylogenetic analysis showed that the FIP-associated strains of FCoV from the outbreak were very closely related to the fecally derived strains of FCoV from contemporary-asymptomatic cats.
Conclusions and Clinical Importance
Sequence analysis provided no evidence that genetically distinct virulent and avirulent strains of FCoV were present during this FIP outbreak.
Feline coronavirus (FCoV) infection is endemic among cats worldwide. In the United Kingdom, around 40% of the domestic cat population has been infected with FCoV and in multicat households, this figure increases to 90%.[1-3] Natural infections with FCoV are often transient and asymptomatic or result in mild gastrointestinal disease. In these cases, the causative FCoV is sometimes referred to as feline enteric coronavirus. However, in some animals, FCoV infection results in the systemic disease of feline infectious peritonitis (FIP), and in these cases the virus has been referred to as FIP virus. FIP usually arises sporadically and unpredictably within a subpopulation or a group of cats. Epizootic FIP, in which FIP arises at an above average frequency in a single locality over a short period of time, is far less common.[4, 5]
The pathogenesis of FIP has been investigated for over 40 years, but remains incompletely understood. Viral factors are thought to be important: in experimental studies FCoV obtained from FIP-affected cats and FCoV obtained from the feces of asymptomatic cats manifest their respective pathogenic phenotypes (FIP or no to mild enteric disease, respectively) when inoculated into cats. Accordingly, 1 recent hypothesis states that there are distinct populations of virulent (FIP-associated) and avirulent (largely localized to the intestines) FCoV strains circulating in cat populations, and that these are independently acquired: this is known as “the circulating virulent/avirulent” hypothesis. An alternative hypothesis states that FIP arises within individual infected cats as a result of mutation(s) in the virus genome: this is known as “the internal mutation” hypothesis.[7-10] However, no specific viral mutation has been identified that is associated with the FIP phenotype.
Phylogenetic studies supporting each of these hypotheses have been published.[6, 8, 10] The circulating virulent/avirulent hypothesis was supported by the phylogenetic clustering of membrane glycoprotein and 7b gene fragment sequences from tissue-derived FCoV strains from FIP-affected cats (n = 8) and fecally derived FCoV strains from asymptomatic cats (n = 48). In contrast, other studies analyzing sequence data from membrane glycoprotein and accessory protein 3c genome fragments from FCoV strains collected from the feces of asymptomatic cats (n = 15 and 27, respectively), and from the tissues of FIP-affected cats (n = 28 and 28, respectively), found phylogenetic clustering according to the geographic location of sampling rather than in association with the disease phenotype. However, both of these studies are difficult to interpret because sampling occurred over protracted periods of time (2–3 years and unspecified), at different geographic locations, and from cats with different genetic and environmental backgrounds.
Recently, the Feline Centre, Langford Veterinary Services, University of Bristol was able to obtain samples from an epizootic outbreak of FIP at a single site cat rescue and rehoming center in the UK. Sampling involved kittens entering the center from July 2010 to January 2011. These samples provided the unique opportunity to investigate the phylogeny of the FCoVs present in an epizootic outbreak of FIP, which, to our knowledge, has not been reported previously. Thus, the aim of this study was to determine whether the strains of FCoV in FIP-affected cats were closely related or genetically distinct from the fecally derived strains of FCoV in contemporary-asymptomatic cats during this FIP outbreak.
Materials and Methods
Samples and RNA Purification
Samples were obtained from 4 kittens with suspected FIP. Postmortem examination was performed immediately after euthanasia of 3 kittens with FIP (named Z/FIP, F/FIP, and J/FIP; euthanized January 19, January 29, and February 4, 2011, respectively), at which time tissue samples were collected and stored in 10% neutral buffered formalin for routine histopathology, and RNA later1 (according to manufacturer's instructions) for RNA purification. Ascitic fluid collected as part of a diagnostic investigation was available for another kitten with suspected FIP (U/FIP; euthanized January 30, 2011). In January 2011, fecal samples were collected from 16 clinically healthy kittens and cats (identified by number) at the same rescue and rehoming center and stored immediately at −80°C. Total RNA was purified from 20 mg of tissue (omentum from kitten J/FIP; colonic lymph node from kitten Z/FIP; mesentery from kitten F/FIP), 100 μL of ascitic fluid (from kitten U/FIP) and from 0.5 g feces (clinically asymptomatic kittens) using a commercially available kit (NucleoSpin RNA II2) as described previously. Formalin fixed tissue from the 3 kittens with FIP for which samples were available (Z/FIP, F/FIP and J/FIP) were subjected to immunohistologic examination for the presence of FCoV antigen. All kittens had been resident at a single site cat rescue and rehoming center in the UK. The following pairs of kittens were litter mates and resident within the same pen: kittens Z-FIP and #80; #65 and #73; #66 and #75. Otherwise the kittens were housed in separate pens within the same complex. Each litter of kittens had been relinquished to the center from different private households and kittens that subsequently went on to develop FIP had been rehomed separately to private households before the onset of clinical signs.
Reverse Transcription PCR and Sequencing
FCoV RNA was amplified by real-time, reverse transcriptase polymerase chain reaction (RT-qPCR) as described previously.
To design gene specific (GSP) reverse transcription and PCR primers, all of the FCoV genome sequences found on the SARGENS website http://veb.lumc.nl/SARGENS/ accessed May 28, 2011 were aligned using ClustalW in MacVector v123 and primers (Table 1) were designed to 4 target regions within the FCoV genome (Fig 1) using Primer 3. The targets comprised of the following: 2 regions within the replicase polyprotein; an amino-proximal region of nsp3, and the carboxyl-proximal region of nsp12 (RNA-dependent RNA polymerase); an amino-proximal region of the surface glycoprotein; and the membrane glycoprotein. All primers were synthesized by Metabion International AG4.
Table 1. Primers used in directed reverse transcription and PCR reactions
Sequence variability in the 5′ region of the surface and membrane glycoproteins necessitated the placement of the forward primer in the preceding highly conserved regions of the nsp16 and small envelope protein genes respectively.
Replicase polyprotein (amino-proximal region of nsp3)
FCoV nsp3 A F1
FCoV nsp3 A R2
Replicase polyprotein (carboxyl-proximal region of nsp12)
FCoV nsp12 B F1
FCoV nsp12 B R1
Amino-proximal region of the surface glycoproteinb
Purified RNA from each sample was reverse transcribed using the ImProm-II Reverse Transcription System5 using 250 ng random hexamers or 500 nM GSP reverse primer, 500 μM each dNTP, and 1–9 μL RNA combined with water to a total volume of 20 μL according to manufacturer's instructions. The resultant cDNA was amplified by PCR using the iProof High-Fidelity PCR Kit6 using 500 nM of each primer, 500 μM each dNTP, and 1 μL cDNA template, combined with water to a total volume of 50 μL. The following thermal cycling protocol was used for the nsp3, nsp12, and the membrane glycoprotein gene fragments: 98°C for 30 seconds and 40 cycles of 98°C for 10 seconds, 59°C for 20 seconds, and 72°C for 30 seconds. The following thermal cycling protocol was used for the surface protein gene fragment: 98°C for 30 seconds and 40 cycles of 98°C for 10 seconds, 62°C for 20 seconds, and 72°C for 45 seconds. After a failure to amplify the surface protein gene fragment from the Z/FIP sample using iProof polymerase, the HotStarTaq Master Mix Kit7 was used with 200 nM of primer (FCoV S1 F1/R1), and 1 μL cDNA template in a total volume of 25 μL, with cycling conditions of 95°C for 15 minutes and 45 cycles of 95°C for 10 seconds, 56°C for 20 seconds, and 72°C for 120 seconds. Positive (FCoV cDNA) and negative (H2O) PCR controls were included in each reaction. Reactions were carried out in either a PTC 200 DNA Engine8 or MJ Mini thermal cycler6.
PCR amplicons were purified (NucleoSpin Extract II2), quantified9, and sequenced10. Because of the length of surface protein gene amplicon, additional sequencing primers were designed using Primer 3 (Table 1).
Nucleotide sequences were aligned using ClustalW, in MacVector v12, with subsequent manual adjustment. Phylogenetic trees were constructed using the neighbor-joining program from a distance matrix, corrected for nucleotide substitutions by the Kimura two-parameter model. Further phylogenetic trees were constructed using maximum likelihood (PhyML v3.0) and parsimony (dnapars v3.67) methods accessed via the Mobyle portal at http://mobyle.pasteur.fr/. The data set was resampled 1,000 times to generate bootstrap percentages. Sequence data corresponding to the same regions of the canine coronavirus genome (GQ477367) were used to root the phylogenetic trees. The FCoV fragments were translated in silico into their corresponding amino acid sequences by Transeq accessed via EMBL at http://www.ebi.ac.uk/Tools/emboss/transeq/, using the standard translation table, then aligned using ClustalW. The FCoV gene fragment sequences were deposited in the European Molecular Biology Laboratory Nucleotide Database (accession numbers HE860440-91).
All of these samples and details were obtained with the full consent of the rescue and rehoming center or owners as appropriate. In the FIP cases, euthanasia was performed on the basis of veterinary advice.
All 3 kittens suspected of having FIP and for which tissues were available had histopathologic changes consistent with FIP (pyogranulomatous parenchymal foci, perivascular mononuclear infiltrates, fibrinous polyserositis), and immunohistologic evidence of FCoV antigen within tissue-associated macrophages, confirming a diagnosis of FIP. FCoV RNA was detected by RT-qPCR in the tissues (threshold cycle values (Cts): J/FIP 15.5, F/FIP 17.1, Z/FIP 17.3) from the kittens with confirmed FIP and the ascitic fluid (U/FIP Ct 29.1) from a kitten with suspected FIP. Nine of the 16 fecal samples from asymptomatic kittens and cats (56%; identified as #65, #66, #67, #71, #73, #75, #76, #77, and #80) were positive for FCoV on RT-qPCR (Ct 18.6–27.8). Of these, four (#66, #71, #76, and #77) have been euthanized (see 'Discussion' for details). The remainder was recorded as alive on or after March 30, 2012.
Using the primer pair nsp3 A F1/R2, a 896 bp fragment of the nsp3 gene was amplified by PCR for each of the FCoV-positive samples, from which sequence data were obtained. Nucleotide identities between the sequences ranged from 99.6 to 100%. All of the amplicon sequences clustered together in a distinct clade when aligned with other FCoV genomes (Fig 2A).
Using the primer pair nsp12 B F1/R1, a 803 bp fragment of the nsp12 gene was amplified by PCR for each of the FCoV-positive samples, from which sequence data were obtained. Nucleotide identities between the sequences were identical for all but one of the samples, which had a single synonymous substitution at one site. All of the amplicon sequences clustered together in a distinct clade when aligned with other FCoV genomes (Fig 2B).
Using the primer pair S1 F1/R1, a 1,881 bp fragment comprising a short 3′ terminal region of the replicase polyprotein (subunit nsp16) gene and the 5′ end of the surface glycoprotein gene (providing approximately 32% coverage of the surface protein gene of FCoV C1Je [DQ848678]) was amplified by PCR for each of the FCoV-positive samples, from which sequence data were obtained. Nucleotide identities between the sequences ranged from 99.0 to 100%. All of the amplicon sequences clustered together in a distinct clade when aligned with other FCoV genomes (Fig 2C).
Using the primer pair M F1/R1, a 1,043 bp fragment comprising a short 3′ terminal region of the small envelope protein gene, and the majority the membrane glycoprotein gene (approximately 90% coverage of the membrane glycoprotein gene of FCoV C1Je) was generated by PCR for each of the FCoV-positive samples, from which sequence data were obtained. Nucleotide identities between the sequences ranged from 99.2 to 100%. All of the amplicon sequences clustered together in a distinct clade when aligned with other FCoV genomes (Fig 2D).
For all genome fragments, maximum likelihood and parsimony methods produced similar phylogenetic trees (with equivalent bootstrap values) to those found by the neighbor-joining method (data not shown).
When sequence data for the outbreak samples were compared with each other there were no nucleotide, or predicted amino acid, motifs that could differentiate between the fecally derived FCoV strains from asymptomatic cats and the tissue- or ascitic fluid-derived FCoV strains from cats with FIP.
In the epizootic outbreak described in this study, postmortem derived tissues or ascitic fluid were available from 4 cats of which 3 were confirmed to have FIP by histopathology and the remaining cat was strongly suspected of having FIP based on clinical features. In each case, the diagnosis of FIP is supported by the amplification of FCoV RNA from their respective tissue or ascitic fluid samples. Unfortunately, the true incidence of FIP was unknown because of the high throughput of cats within the center and minimal available follow-up data. Of the 16 fecal samples collected from contemporaneous asymptomatic cats, 9 (56%) contained FCoV RNA. This is similar to what was found in a study that identified FCoV shedding in 60% of cats 1 week after arriving at a rescue shelter. More than 1 year postsampling, 5 of the 9 contemporaneous asymptomatic cats remain alive and without any signs that could be suggestive of FIP over 1 year postsampling. We therefore suggest that these isolates can, with some certainty, be considered as feline enteric coronavirus infections based on their biological behavior. However, as noted, four of the contemporaneous asymptomatic cats were euthanized subsequently. Two of these cats were euthanized at the rehoming center with nonspecific clinical signs; the other 2 cats had developed signs potentially consistent with FIP (eg, malaise, abdominal fluid) after rehoming to new owners and had been euthanized (postmortem samples were not available). Consequently, we are unable to assign the samples from these animals to the FIP or nonFIP groups. This illustrates the caution needed during sample collection but does not invalidate the conclusions of this study.
The sporadic and relatively infrequent incidence of FIP has always confounded the problem of collecting multiple contemporaneous samples from cats with FIP and asymptomatic cats living in the same location. In 1 study of 73 FCoV seropositive multicat households FIP was encountered at an incidence rate of 4.8% within the first 3 years of entering the household. In contrast, an epizootic FIP outbreak is defined as occurring where there is an incidence of FIP greater than 10% in cats within an establishment, and the higher incidence of FIP will clearly facilitate the collection of relevant samples. However, very few epizootic FIP outbreaks have been described in the literature.
The primers designed for this study targeted a number of regions within the FCoV genome. The sites chosen are representative of regions of low (amino-proximal region of the surface protein), intermediate (membrane protein), and high (carboxyl-proximal region of nsp12) conservation, as well as a region that is variable in length (amino-proximal region of nsp3). Consequently, taken together, these amplicons provide an overall picture of genetic relatedness and are appropriate for phylogenetic analysis. The primers in combination with a high-fidelity DNA polymerase (iProof High-Fidelity) were successful in generating amplicons of the correct size for all samples, except for the tissue of 1 FIP-affected cat (Z-FIP). In this case, using the surface protein gene primer pair, a diffuse band of a lower molecular weight PCR product was generated. In this sample, an alternative DNA polymerase (HotStarTaq) was subsequently used successfully to generate an amplicon of an appropriate size, sequence data from repeated reactions were identical.
All of the FCoV sequences derived in this study, both from tissues with typical FIP lesions and from the asymptomatic cat feces, clustered together, and separately from all other FCoVs that were analyzed. This was true for all of the phylogenetic trees generated for each of the genome fragments, (Fig 2A–D). Thus, this study provides no evidence for the presence of 2 distinct FIP tissue-associated and fecally derived strains of FCoV in the cats associated with this FIP outbreak.
This conclusion is in contrast to a previous report where membrane glycoprotein and accessory protein 7b gene fragments from FCoV RNA derived from the feces of healthy cats formed clusters distinct from sequences derived from FIP-associated FCoV RNA. However, these results are in agreement with another study, which found that accessory protein 3c and membrane glycoprotein FCoV gene sequences from fecally-derived RNA from healthy cats and from RNA derived from tissues with typical FIP lesions from sporadic cases of FIP were generally clustered according to the cattery from where they originated.[8, 11] Our data also lead to the conclusion that the cats in this study were likely infected with FCoV from the same source upon entering the rescue center; although it cannot be ruled out that the cats were exposed to very closely related strains of FCoV circulating in the geographic region before entering the center.
In addition to proposing the “circulating virulent/avirulent hypothesis”, Brown et al suggested that a specific amino acid motif within the membrane glycoprotein could be used to differentiate between the different phenotypes of FCoV. This was challenged by a later study that found no association between the proposed motif and virulent and avirulent phenotypes. The data generated in this study show that the amino acid motif YVIAL (positions 108, 120, 138, 163, and 199 based on reference sequence for TGEV GenBank no. NP058427) was predicted for all of the viruses that we analyzed. This motif arrangement was not one of the amino acid combinations (YIIAL associated with FIP; HIIVI/HIIVL/HVIAL/YVVAL associated with asymptomatic cats; and YIVAL seen in association with both FIP and asymptomatic cats), suggested in the original article. Also, the YVIAL motif has been reported subsequently in both FIP-associated FCoVs and fecally-derived FCoVs. Moreover, in this study there were no RNA or amino acid motifs identified, in any of the gene fragments, which were associated with any specific disease phenotype. It has to be noted that this study, as with previous phylogenetic analyzes of FCoV genomes, was limited by only partial genome coverage (approximately 16%). Future study involving whole genome sequencing will be needed to identify any specific virus determinant associated with the development of FIP.
The authors thank colleagues (especially Rachel Korman) at the Feline Centre, Langford Veterinary Services, University of Bristol, United Kingdom and local veterinary practices and shelters, for their help in the acquisition of samples used in this study. We would also like to thank Professor Anja Kipar, Veterinary Pathology, School of Veterinary Science, and the technicians of the Histology Laboratory, Veterinary Laboratory Services, School of Veterinary Science, University of Liverpool, United Kingdom for performing and interpreting the geline coronavirus immunohistology on tissue sections of all cases. Research was funded by a European Society of Veterinary Internal Medicine Clinical Studies Fund grant. CT was supported by a Wellcome Trust Veterinary Vacation Scholarship.
Conflict of Interest Declaration: Authors disclose no conflict of interest.